These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 705693)

  • 1. Comparison of reagents for determining the activated partial thromboplastin time.
    Hoffmann JJ; Meulendijk PN
    Thromb Haemost; 1978 Jun; 39(3):640-5. PubMed ID: 705693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
    Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
    Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated partial thromboplastin time reagents: an evaluation.
    Howarth S
    Br J Biomed Sci; 1993 Jun; 50(2):109-13. PubMed ID: 8219915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL; Howard C
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W
    Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A; Mischke R; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies.
    Bowyer A; Kitchen S; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):154-8. PubMed ID: 20840376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four commercially available activated partial thromboplastin time reagents using a semi-automated coagulometer.
    Shetty S; Ghosh K; Mohanty D
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):493-7. PubMed ID: 12851537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation among commercial activated partial thromboplastin time reagents in response to heparin.
    Shapiro GA; Huntzinger SW; Wilson JE
    Am J Clin Pathol; 1977 May; 67(5):477-80. PubMed ID: 857645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays.
    Kitchen S; Preston FE
    Thromb Haemost; 1996 May; 75(5):734-9. PubMed ID: 8725715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the demonstration of a factor VIII or IX deficiency by means of partial thromboplastin time].
    Lutze G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):933-7. PubMed ID: 64436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of factor VIII:C activity on the activated partial thromboplastin time (aPTT) in the dog. Adaptation of the aPTT as a screening test for canine hemophilia A?].
    Mischke R
    Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):219-22. PubMed ID: 8339706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin formation, fibrinopeptide A release, and platelet thrombus dimensions on subendothelium exposed to flowing native blood: greater in factor XII and XI than in factor VIII and IX deficiency.
    Weiss HJ; Turitto VT; Vicic WJ; Baumgartner HR
    Blood; 1984 May; 63(5):1004-14. PubMed ID: 6713090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of six activated partial thromboplastin time reagents: intrinsic system factors' sensitivity and responsiveness.
    Hales SC; Johnson GS; Wagner D
    Clin Lab Sci; 1990; 3(3):194-6. PubMed ID: 10149038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.